TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / Blackthorn Therapeutics Stock

Blackthorn Therapeutics Stock

blackthornrx.comHealthcareFounded: 2015Funding to Date: $130.3MM

BlackThorn Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of targeted medicines for the treatment of central nervous system (CNS) disorders.

Buy or sell Blackthorn Therapeutics stockLearn more about Blackthorn Therapeutics IPO
Register for Details

For more details on financing and valuation for Blackthorn Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Blackthorn Therapeutics.

Register Today

Team

Management Team

Edward Roberts Ph.D
Scientific Co-Founder
Paul Berns
Executive Chairman
William Martin Ph.D
Co-Founder, President, Chief Executive Officer & Board Member
Jane Tiller MD
Chief Medical Officer
Monique Levy
Chief Strategy Officer
Hugh Rosen Ph.D
Scientific Co-Founder

Board Members

John MacPhee
Julie Sunderland
Biomatics Capital
Matthew Fust
William Martin Ph.D
Brian Chee
Polaris Partners
Lori Hu
Vertex Ventures HC
Asish Xavier Ph.D
Johnson & Johnson Innovation - JJDC
Kristina Burow
ARCH Venture Partners
Paul Berns

Other companies like Blackthorn Therapeutics in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Colossal Biosciences
Sector
Healthcare
 
 
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
Cytonics
Sector
Healthcare
 
 
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Precision Neuroscience
Sector
Healthcare
 
 

News

Business Wire 10/21/2019
BlackThorn Therapeutics Appoints William J. Martin, Ph.D., as Chief Executive Officer to Lead Next Stage of Growth
BlackThorn Therapeutics, Inc., today announced the promotion of company co-founder and seasoned CNS drug discovery and development expert, William J.
TechCrunch 06/13/2019
Neurobehavioral health company BlackThorn pulls in $76 million from GV to treat mental disorders – TechCrunch
There are numerous challenges to finding effective treatments for mental disorders. However, BlackThorn Therapeutics, a neurobehavioral health company using machine learning to create personalized medicine for mental health, is betting its technological approach to finding drugs that work will put …

Trending Companies

Frequently Asked Questions